Pharma Journalist -

Pfizer announced that it is reviewing strategic alternatives for its Consumer Healthcare business. A range of options will be considered, including a full or partial separation of the…
Read More...

Flexion Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved Zilretta™ (triamcinolone acetonide extended-release injectable suspension), the first and only…
Read More...

Mithra announces that Health Canada has accepted the Marketing Authorization Application for its complex therapeutic Tibelia, the company's tibolone-based product for use in Hormone…
Read More...

MilliporeSigma today officially opened its new Life Science Center in Burlington, Massachusetts. The new center serves as a regional hub for scientific advancement and customer…
Read More...

BioTime reported that an investigator-led clinical trial has successfully treated its first patient in a study of Premvia as a carrier for stromal vascular fraction cells (SVF) for the…
Read More...

Izun Pharmaceuticals Corporation announced that the results from a recently completed double blind, Phase 2 clinical study in oral mucositis indicated promising positive outcomes for…
Read More...

Titan Pharmaceuticals announced that the first patient has been treated in a Phase 1/2 trial of the company's ropinirole implant intended for the treatment of the signs and symptoms of…
Read More...

Janssen Biotech announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for apalutamide, an investigational, next generation oral…
Read More...

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative…
Read More...

Kaleido Biosciences announced an agreement with CoreBiome, a genomics platform company focused on accelerating microbiome innovation with expert genomics and big-data analytics, to…
Read More...